Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer.
Journal: Targeted oncology
Published: January 30, 2023
Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.
Journal: Breast cancer research : BCR
Published: February 01, 2017
Subtype and pathway specific responses to anticancer compounds in breast cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 18, 2011
Showing 1-3 of 3
Last Updated: 09/26/2026